These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 27881012)
41. Elevated Preoperative Serum Alanine Aminotransferase/Aspartate Aminotransferase (ALT/AST) Ratio Is Associated with Better Prognosis in Patients Undergoing Curative Treatment for Gastric Adenocarcinoma. Chen SL; Li JP; Li LF; Zeng T; He X Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27294917 [TBL] [Abstract][Full Text] [Related]
42. Prognostic factors in malignant pleural mesothelioma: a retrospective study. Suzuki H; Hirashima T; Kobayashi M; Okamoto N; Matsuura Y; Tamiya M; Morishita N; Okafuji K; Shiroyama T; Morimura O; Morita S; Kawase I Intern Med; 2012; 51(7):707-10. PubMed ID: 22466824 [TBL] [Abstract][Full Text] [Related]
43. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254 [TBL] [Abstract][Full Text] [Related]
44. The role of lymphocyte-monocyte ratio on axial spondyloarthritis diagnosis and sacroiliitis staging. Wang J; Su J; Yuan Y; Jin X; Shen B; Lu G BMC Musculoskelet Disord; 2021 Jan; 22(1):86. PubMed ID: 33453722 [TBL] [Abstract][Full Text] [Related]
45. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer]. Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215 [No Abstract] [Full Text] [Related]
46. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy. Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209 [TBL] [Abstract][Full Text] [Related]
47. [Analysis of related factors of poor prognosis in children with parenteral nutrition-associated cholestasis]. Yi W; Yu X; Yu L; Xiong X; Jiang Z; Zhou L; Qiu Y; Yan S Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):731-735. PubMed ID: 34296695 [TBL] [Abstract][Full Text] [Related]
48. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer. Temur I; Kucukgoz Gulec U; Paydas S; Guzel AB; Sucu M; Vardar MA Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():25-29. PubMed ID: 29804024 [TBL] [Abstract][Full Text] [Related]
49. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. Song A; Eo W; Lee S World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648 [TBL] [Abstract][Full Text] [Related]
50. Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma. Jiang R; Cai XY; Yang ZH; Yan Y; Zou X; Guo L; Sun R; Luo DH; Chen QY; Huang PY; Xiang YQ; Lu X; Wang L; Xia WX; Mai HQ; Chen MY Chin J Cancer; 2015 Jun; 34(6):237-46. PubMed ID: 26067059 [TBL] [Abstract][Full Text] [Related]
51. Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer. Feng F; Zheng G; Wang Q; Liu S; Liu Z; Xu G; Wang F; Guo M; Lian X; Zhang H BMC Gastroenterol; 2018 Oct; 18(1):148. PubMed ID: 30305076 [TBL] [Abstract][Full Text] [Related]
52. The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy. Rambaldi A; Boschini C; Gritti G; Delaini F; Oldani E; Rossi A; Barbui AM; Caracciolo D; Ladetto M; Gueli A; De Crescenzo A; Passera R; Devizzi L; Patti C; Gianni AM; Tarella C Am J Hematol; 2013 Dec; 88(12):1062-7. PubMed ID: 23940056 [TBL] [Abstract][Full Text] [Related]
53. Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: Results from a large cohort. Yuan C; Li N; Mao X; Liu Z; Ou W; Wang SY Thorac Cancer; 2017 Jul; 8(4):350-358. PubMed ID: 28544400 [TBL] [Abstract][Full Text] [Related]
54. Ratio of Immune Response to Tumor Burden Predicts Survival Via Regulating Functions of Lymphocytes and Monocytes in Diffuse Large B-Cell Lymphoma. Ji H; Niu X; Yin L; Wang Y; Huang L; Xuan Q; Li L; Zhang H; Li J; Yang Y; An W; Zhang Q Cell Physiol Biochem; 2018; 45(3):951-961. PubMed ID: 29428948 [TBL] [Abstract][Full Text] [Related]
55. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer. Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763 [TBL] [Abstract][Full Text] [Related]
56. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer. Sierzega M; Lenart M; Rutkowska M; Surman M; Mytar B; Matyja A; Siedlar M; Kulig J Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341 [TBL] [Abstract][Full Text] [Related]
57. Prognostic factors in diffuse malignant pleural mesothelioma: effects of pretreatment clinical and laboratory characteristics. Metintas M; Metintas S; Ucgun I; Gibbs AR; Harmanci E; Alatas F; Erginel S; Tel N; Pasaoglu O Respir Med; 2001 Oct; 95(10):829-35. PubMed ID: 11601750 [TBL] [Abstract][Full Text] [Related]
58. A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients - a retrospective file review. Özdin S; Sarisoy G; Böke Ö Nord J Psychiatry; 2017 Oct; 71(7):509-512. PubMed ID: 28644753 [TBL] [Abstract][Full Text] [Related]
59. Defining the optimal cut-off values for liver enzymes in diagnosing blunt liver injury. Koyama T; Hamada H; Nishida M; Naess PA; Gaarder C; Sakamoto T BMC Res Notes; 2016 Jan; 9():41. PubMed ID: 26809874 [TBL] [Abstract][Full Text] [Related]
60. Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management. Del Prete M; Giampieri R; Loupakis F; Prochilo T; Salvatore L; Faloppi L; Bianconi M; Bittoni A; Aprile G; Zaniboni A; Falcone A; Scartozzi M; Cascinu S Oncotarget; 2015 Oct; 6(32):33982-92. PubMed ID: 26334693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]